These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1289605)

  • 1. [Effect of oral adsorbent (AST-120) in the rat model of chronic renal failure induced by adriamycin].
    Yoshida Y; Ise M
    Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1055-9. PubMed ID: 1289605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effects of oral adsorbent (AST-120) in the experimental model of chronic renal failure--pathophysiological study on renal function, glomerular hypertrophy, mesangial function and glomerular histology].
    Yoshida Y; Sakai T; Asakura K; Sugano M; Ise M; Uehara Y
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):1001-8. PubMed ID: 2263021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet.
    Imai E; Takenaka M; Isaka Y; Moriyama T; Akagi Y; Kakuchi J; Fujii T; Ito T; Hori M; Horio M; Syoji T; Tsubakihara Y
    Clin Exp Nephrol; 2003 Jun; 7(2):113-9. PubMed ID: 14586729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an oral adsorbent (AST-120) in rats with daunomycin-induced chronic renal failure.
    Shimizu K; Maeda K; Shibata M; Ise M; Sugano M; Uehara Y
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):507-11. PubMed ID: 1895550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral adsorbent in the rat model of chronic renal failure.
    Yoshida Y; Sakai T; Ise M
    Nephron; 1992; 62(3):305-14. PubMed ID: 1436344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathological study on the effect of oral adsorbent AST-120 on chronic renal failure in rats].
    Kuwao S; Sakai T; Kumano K; Ise M; Uehara Y
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):731-41. PubMed ID: 1770633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure.
    Okada K; Okawa E; Shibahara H; Maruyama T; Maruyama N; Matsumoto K; Takahashi S
    Kidney Blood Press Res; 2004; 27(4):218-25. PubMed ID: 15273424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral adsorbent AST-120 ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generation.
    Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Suzuki T; Ueda Y; Yamagishi S
    Metabolism; 2011 Feb; 60(2):260-4. PubMed ID: 20189611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of oral-adsorbent (AST-120) in chronic renal failure (CRF) in rats].
    Sakai T; Kumano K; Takara S; Kuwao S; Ise M; Sugano M; Uehara Y
    Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):359-65. PubMed ID: 2747009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure.
    Komiya T; Miura K; Tsukamoto J; Okamura M; Tamada S; Asai T; Tashiro K; Kuwabara N; Iwao H; Yoshikawa J
    Int J Mol Med; 2004 Jan; 13(1):133-8. PubMed ID: 14654984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study.
    Owada A; Nakao M; Koike J; Ujiie K; Tomita K; Shiigai T
    Kidney Int Suppl; 1997 Dec; 63():S188-90. PubMed ID: 9407455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of oral adsorbent AST-120 in rats with chronic renal failure--mechanism of progression of renal failure by dietary protein].
    Niimura F; Ise M; Uehara Y; Kumano K; Sakai T
    Nihon Jinzo Gakkai Shi; 1992 Mar; 34(3):261-71. PubMed ID: 1630028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approach for chronic renal failure model by direct kidney injection of doxorubicin in rats.
    Yoneko M; Kamei J; Ito CF; Kojima J
    Methods Find Exp Clin Pharmacol; 2007; 29(6):389-94. PubMed ID: 17922066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis.
    Aoyama I; Enomoto A; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S8-14. PubMed ID: 12612943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral sorbent AST-120 increases renal NO synthesis in uremic rats.
    Tumur Z; Niwa T
    J Ren Nutr; 2008 Jan; 18(1):60-4. PubMed ID: 18089446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake.
    Horike K; Usami T; Kamiya Y; Kamiya T; Yoshida A; Itoh S; Yamato H; Ise M; Kimura G
    Clin Exp Nephrol; 2003 Jun; 7(2):120-4. PubMed ID: 14586730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients.
    Niwa T; Nomura T; Sugiyama S; Miyazaki T; Tsukushi S; Tsutsui S
    Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
    Tsubakihara Y; Takabatake Y; Oka K; Shoji T; Togawa M; Okada N; Takahito I; Imai E
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early morphological changes of tubules in rats with chronic renal failure.
    Okada K; Takahashi S; Nagura Y; Hatano M; Shimamura T
    Nihon Jinzo Gakkai Shi; 1992 Jan; 34(1):65-70. PubMed ID: 1593798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for "uremic toxin" in the progressive loss of intact nephrons in chronic renal failure.
    Motojima M; Nishijima F; Ikoma M; Kawamura T; Yoshioka T; Fogo AB; Sakai T; Ichikawa I
    Kidney Int; 1991 Sep; 40(3):461-9. PubMed ID: 1787646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.